Not available
Quote | Abbott Laboratories (NYSE:ABT)
Last: | $104.59 |
---|---|
Change Percent: | -0.09% |
Open: | $104.1 |
Close: | $104.59 |
High: | $104.83 |
Low: | $104.1 |
Volume: | 5,318,207 |
Last Trade Date Time: | 05/15/2024 03:00:00 am |
News | Abbott Laboratories (NYSE:ABT)
2024-05-15 17:47:35 ET Tudor Investment Corp. the hedge fund founded by billionaire investor Paul Tudor Jones, took a fresh equity stake in PayPal ( NASDAQ: PYPL ) during Q1 2024, buying about 888K shares, it said in its latest 13F filing dated Wednesday. It also opened a new equity...
2024-05-15 11:21:16 ET More on Abbott Laboratories Why I Believe Abbott Is Much Better Positioned In Today's Rising Inflation Scenario Abbott Laboratories (ABT) Q1 2024 Earnings Call Transcript Abbott Laboratories: Organic Growth Will Be Key To Q1 Earnings Ab...
Message Board Posts | Abbott Laboratories (NYSE:ABT)
Subject | By | Source | When |
---|---|---|---|
$ABT 1Q23 CC transcript: | DewDiligence | investorshub | 04/20/2023 3:39:39 PM |
$ABT 1Q23 Results by Business Segment | DewDiligence | investorshub | 04/19/2023 3:45:11 PM |
$ABT reports 1Q23 resultsslightly increases 2023 guidance: | DewDiligence | investorshub | 04/19/2023 3:44:34 PM |
whytestocks: $ABT News Article - Abbott Laboratories (NYSE: ABT) is a Leading Gainer in Wednesday Mo | whytestocks | investorshangout | 04/19/2023 3:35:46 PM |
FreeStyle Libre gets expanded Medicare coverage: | DewDiligence | investorshub | 04/17/2023 4:17:29 PM |
News, Short Squeeze, Breakout and More Instantly...
Abbott Laboratories Company Name:
ABT Stock Symbol:
NYSE Market:
The Nasdaq 100 closed slightly lower on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it coul...
2024-05-08 07:16:00 ET Healthcare doesn't get the hype that other industries -- say, technology -- get. However, there arguably isn't an industry more important to humankind's well-being. That's especially true in the United States, the world's most lucrative healthcare market -- a multi-tr...
Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee PR Newswire More than 20 million people in the U.S. are living with peripheral artery disease (PAD) yet there have been limited treatment options The first-of-its-kind Esprit™ B...